Skip to: [Content] [Navigation]

LiquiBand® Optima - Skin Adhesive - Wins Medical Design Excellence Award
MedLogic Global Ltd cited for its role as research and development and manufacturer of topical skin adhesive

MedLogic Global Ltd (subsidiary of Advanced Medical Solutions Group Plc.), a UK based wound care company that manufactures and supplies market leading cyanoacrylate skin adhesives and sealants, today announced that LiquiBand® Optima has received a 2009 Medical Design Excellence Award.  LiquiBand® Optima is an advanced topical cyanoacrylate skin adhesive that sets new standards for minor wound closure Launched in Europe in September 2008  LiquiBand® Optima is a pre-assembled skin adhesive device that can be used straight from the pack, the unique winged actuator provides an easy ‘click-and-use’ functionality that ensures precision control.  LiquiBand® Optima enables the emergency room clinician to perform quicker, safer and more precise wound closure that helps achieve excellent cosmetic results.  The Octyl-BlendTM cyanoacrylate technology, used within LiquiBand® Optima, allows the product to be stored at ambient temperature using an optimized, no-sting monomer formulation.

The Medical Design Excellence Awards competition is organized and presented by Canon Communications LLC (Los Angeles) and is the only awards program that exclusively recognizes contributions and advances in the design of medical products. Entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.

A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics.

 “We are honored to be recognized by the MDEA judges,” said Richard Stenton, General Manager for MedLogic Global Ltd.  “We worked very closely with clinicians in the development of LiquiBand® Optima to improve on the safety and ease of use of cyanoacrylate based wound closure technology.  LiquiBand® Optima has been extremely well received and feedback has indicated that this innovative design offers significant clinical advantages, making wound closure easier and safer for both patient and clinician.”

The 2009 Medical Design Excellence Award winners will be honored at a ceremony during theMedical Design & Manufacturing (MD&M) East Conference and Exposition, June 9–11, 2009,at New York City’s Jacob K. Javits Convention Center. Gold and silver award recipients will beannounced at this time.

For more information contact MedLogic Global Ltd on +44 1752 209 955 or visit www.liquiband.com

 

 

back to top